GlassScriptPhysician profile
Mahmoud Malas
NPI 1013953892
$124,187.20
in general payments reported to CMS, 2019-2025
26 companies · $37K in 2025
The $37K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $3,202 · 2021: $2,688 · 2022: $7,990 · 2023: $2,504 · 2024: $48K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Grant: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Education: $10K · Food and Beverage: $5,051 · Travel and Lodging: $2,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,600.00 |
| Grant | $21,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,050.00 |
| Education | $10,400.00 |
| Food and Beverage | $5,051.02 |
| Travel and Lodging | $2,384.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $49,181.91 | 2021-2025 | Angioguard, Precise Pro Rx, Mynx Control |
| Medtronic, INC. | $22,148.03 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Silk Road Medical, INC. | $19,425.08 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $10,539.15 | 2021-2024 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter |
| Artegraft INC. | $6,867.07 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $4,217.13 | 2019-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Lemaitre Vascular, INC. | $3,629.76 | 2019-2025 | Artegraft Vascular Graft |
| Endologix LLC | $1,966.82 | 2019-2025 | Endocross Device, Torus Stent Graft System |
| Cook Medical LLC | $1,665.13 | 2019-2025 | Zilver Ptx, Beacon Tip Torcon Nb, Icast Covered Stent System, 6mmx22mmx120cm |
| Bolton Medical INC | $979.56 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Philips North America LLC | $890.11 | 2021-2023 | |
| Ge Healthcare | $674.96 | 2023-2025 | |
| Abbott Laboratories | $578.17 | 2019-2020 | |
| Boston Scientific Corporation | $325.60 | 2019-2025 | Enroute Transcarotid Stent |
| Angiodynamics, INC. | $189.89 | 2023-2025 | Auryon Laser System 100-120 Vac |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $155.69 | 2019 | |
| Penumbra, INC. | $144.81 | 2023 | Penumbra System |
| Inspiremd LTD | $123.37 | 2025 | Cguard Prime Carotid Stent System |
| Artivion, INC. | $120.00 | 2023 | Amds-Ascyrus Medical, Jotec Products, Vascular |
| Terumo Medical Corporation | $112.00 | 2021 | |
| Medtronic Vascular, INC. | $103.83 | 2019 | |
| Cardiovascular Systems INC. | $65.07 | 2022 | |
| Becton, Dickinson and Company | $54.29 | 2024 | Crosser Iq |
| Davol INC. | $16.27 | 2021 | |
| Merit Medical Systems INC | $13.50 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Malas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.